In this issue: New treatment for prostate cancer; avastin and breast cancer; new CMS disclosure rule; and FDA actions.
A number of previous reviews in OB/GYN Clinical Alert, including a Special Feature, have been devoted to preterm birth (PTB), a problem that has been on the rise in the United States despite significant efforts to curb it.
In this retrospective study of young women performed in New Zealand between 2005 and 2009, 57% of 452 patients with biopsy-proven cervical intraepithelial neoplasia (CIN) 2 were treated immediately whereas 157 (35%) met the criteria for conservative management.
Women who carry a deleterious germline mutation in BRCA1 or BRCA2 have a substantially higher lifetime risk of developing ovarian cancer.
Lead II rhythm strip from a patient with palpitations? What would you do?
An outbreak of dengue fever in northeastern Kenya has recently sickened at least 5,000 people.
Most patients with ST-elevation myocardial infarction (STEMI) present to hospitals that are not capable of percutaneous coronary intervention (PCI).
Venous thromboembolism (VTE) prophylaxis interventions in gynecologic surgery are meritorious, supported by Level 1 evidence and the subject of multiple guidelines, including those published by the American College of Obstetricians and Gynecologists. However, new evidence suggests nearly one-third of women undergoing hysterectomy in this country still receive no VTE prophylaxis, placing thousands of women at unnecessary risk for preventable morbidity.
